Hyperinsulinemia is often viewed as a compensatory mechanism for insulin resistance, but studies have shown that high levels of insulin may also contribute to insulin resistance. The precise mechanisms by which hyperinsulinemia contributes to insulin resistance remain poorly defined. To understand the direct effects of prolonged exposure to excess insulin in muscle cells, we incubated differentiated C2C12 mouse myotubes with elevated insulin for 16 hours, followed by a 6-hour period of serum starvation, before examining key insulin signaling nodes. Using our model, we found that prolonged high insulin treatment significantly increased the phosphorylation of insulin receptor (INSR) and AKT, but not ERK. After serum starvation, acute AKT and ERK signaling stimulated by 0.2 -20 nM insulin were attenuated. INSR protein levels were significantly downregulated by hyperinsulinemia in an insulin-dose-dependent manner, which resulted in the comparative reduction of acute insulin signaling. Surface INSR was also reduced proportionally to total INSR levels. Mechanistically, we found that both isoforms of Insr mRNA were reduced by hyperinsulinemia and implicated the transcription factor FOXO1. Interestingly, 6h serum starvation reversed the effects of high insulin on basal phosphorylation of INSR, AKT and FOXO1, and Insr transcription. Finally, we validated our results in vivo by determining that INSR levels in mouse skeletal muscle were negatively correlated with circulating insulin. Together, our findings shed light on the mechanisms underlying hyperinsulinemia-induced insulin resistance in muscle cells, which are likely to be relevant in the pathogenesis of type 2 diabetes.
Introduction
Hyperinsulinemia and insulin resistance are cardinal features of type 2 diabetes (T2D) and highly associated with each other. It is a widely held view that insulin resistance is the primary cause of type 2 diabetes and that hyperinsulinemia is a compensatory response (1, 2) . However, a growing body of evidence suggests the opposite may be true in many cases (3) (4) (5) .
Hyperinsulinemia can be observed prior to insulin resistance in obesity and T2D (6) (7) (8) and
hyperinsulinemia is the strongest predictor of T2D in long-term studies (9, 10) . We recently showed that hyperinsulinemia contributes causally to age-dependent insulin resistance in the absence of hyperglycemia (11) . Reducing hyperinsulinemia using partial insulin gene knockout prevents and reverses diet-induced obesity in adult mice (11) (12) (13) . Rodents (14,15), healthy humans (16,17), and people with type 1 diabetes (18) subjected to prolonged insulin administration also have reduced insulin responsiveness independent of hyperglycemia, strongly suggesting that hyperinsulinemia is a self-perpetuating cause of insulin resistance. In the present study, we employed a model of in vitro insulin resistance using a muscle cell line and confirmed our observations in vivo using mice with variable hyperinsulinemia. We found that prolonged hyperinsulinemia induced insulin resistance featuring blunted acute AKT and ERK signaling and transcriptional INSR downregulation via FOXO1 activity. Our data illuminate the mechanism by which hyperinsulinemia contributes to insulin resistance in muscle cells.
Results

Hyperinsulinemia induces insulin resistance in muscle cells in vitro
Circulating insulin in humans oscillates in a range between 0.03 nM and 1.9 nM, and fasting insulin less than 0.17 nM is considered normal (24). To establish a muscle cell model of hyperinsulinemia-induced insulin resistance, we incubated differentiated mouse C2C12 myotubes for 16 hours in a physiologically high insulin dose of 2 nM or superphysiologically high dose of 3 200 nM (Fig. 1A) . Insulin levels at the end of this hyperinsulinemia period were confirmed to be hyperinsulinemic ( Fig. 1A') . After 6-hour serum starvation, acute insulin signaling was characterized by measuring the phosphorylation of AKT and ERK proteins, which represent two major insulin signaling nodes (25). Since alterations in the basal state of the insulin signal transduction network have also been reported in hyperinsulinemic humans and animals (26) , we also measured the effects of hyperinsulinemia on AKT and ERK phosphorylation before and after serum starvation. These experiments showed that total AKT protein levels were significantly downregulated by prolonged 200 nM, but not 2 nM, insulin treatment, while ERK abundance was not significantly changed ( Fig. 1C,D) . After prolonged 200 nM insulin and before serum starvation, AKT phosphorylation at threonine (T) 308 and serine (S) 473 was significantly elevated, but ERK phosphorylation was unaffected ( Fig. 1E,F ). Of note, phosphorylation of ERK1/2 was increased by serum starvation alone, as previously reported in other cell types ( Fig. 1F ) (27) . Acute AKT and ERK signaling in the context of 2 nM acute insulin was significantly reduced by hyperinsulinemia treatment in an insulin dose-dependent manner ( Fig. 1E ,F). We also characterized the insulin dose-and time-dependent signaling in our in vitro hyperinsulinemia model (200 nM insulin).
Phosphorylation of AKT and ERK1/2 were significantly reduced under 0.2, 2, or 20 nM insulin stimulations ( Fig. 2A,B ). Together, these results establish a robust muscle cell insulin resistance model induced by hyperinsulinemia and characterized its effects on basal and acute insulin signaling.
Hyperinsulinemia reduces INSR protein abundance but not its phosphorylation or internalization
To better understand the effects of hyperinsulinemia on the earliest stages of insulin signalling, we examined on INSR abundance, phosphorylation, and internalization. Remarkably, we found the total INSR protein abundance was robustly decreased in both hyperinsulinemia groups in an insulin dose-dependent manner ( Fig. 3B ). Serum starvation also slightly recovered the INSR downregulation in 200 nM insulin group (Fig. 3B ). These results clearly demonstrated that hyperinsulinemia can modulate INSR abundance in this cell system.
We also examined INSR tyrosine 1150/1151 autophosphorylation, which is an early step of insulin signaling that recruits IRS and SHC, leading to PI3K-AKT or RAS-ERK activation (25).
Before starvation, both hyperinsulinemia groups had increased INSR phosphorylation, suggesting that there was continuous insulin signaling during the high insulin treatments ( Impaired INSR endocytosis has been implicated in insulin resistance (28, 29) . Basal surface INSR, as well as dose-and time-dependent INSR internalization were examined in our hyperinsulinemia model using a surface biotinylation assay ( Fig. 4A ). Serum starvation slightly decreased surface-to-total INSR ratio, while hyperinsulinemia had no significant effects ( Fig. 4B ).
Upon acute insulin stimulation, internalized to total INSR ratio did not have evident differences except for a small increase when stimulated by 2 nM insulin ( Fig. 4B ). Therefore, hyperinsulinemia-induced insulin resistance may be mediated by a reduction in total INSR that results in a proportional reduction in INSR protein at the cell surface. The fraction of INSR internalized during acute insulin signaling is not drastically affected by hyperinsulinemia.
Collectively, our experiments suggest that hyperinsulinemia-induced insulin resistance is mediated in large part by a reduction in total INSR, and not by affecting its activity or internalization.
Hyperinsulinemia decreases Insr mRNA via FOXO1 inhibition
One possible cause of INSR downregulation would be the reduced expression of the Insr gene (21). To test this hypothesis, we measured the mRNA of Insr isoforms A and B (Insr-A and Insr-B) by qPCR. In our hands, Insr-A is the predominant isoform in C2C12 myotubes ( Fig. 5A ).
Both Insr-A and Insr-B mRNA were equally downregulated after hyperinsulinemia and partially recovered after serum starvation ( Fig. 5A ), consistent with the change of INSR protein abundance.
Interestingly, insulin-like growth factor 1 receptor (Igfr1), which has similar structure and signaling as INSR, was also reduced by hyperinsulinemia at the transcriptional level ( Fig. 5B ). Alteration in Insr alternative splicing has been implicated in hyperinsulinemia (30) . In our model, the ratio of Insr-A and Insr-B mRNA was not affected by hyperinsulinemia or serum starvation ( Fig. 5C ). Our evidence suggests that hyperinsulinemia and serum starvation regulate INSR protein abundance by regulating Insr mRNA levels.
Forkhead box protein O1 (FOXO1) is a known transcriptional regulator of the Insr gene and is also a key mediator of insulin signaling (31) (32) (33) . In Drosophila and mouse myoblasts, FOXO1 activity is necessary and sufficient to increase Insr transcription under serum fasting and reverse this effect in the presence of insulin (32) . Therefore, we sought to determine the activity of FOXO1 in our hyperinsulinemic model. Indeed, high insulin inhibited FOXO1 via increased phosphorylation on T24, which is an AKT-associated event known to exclude this protein from the nucleus and decrease FOXO transcriptional activity (34), but did not affect total FOXO1 abundance ( Fig. 5D ). T24 phosphorylation of FOXO1 significantly decreased after starvation ( Fig.   5D ), consistent with our observed effects on AKT phosphorylation and Insr transcription. Together, these data strongly suggest that hyperinsulinemia downregulates Insr transcription via FOXO1 phosphorylation.
Circulating insulin negatively correlates with INSR level in vivo
To validate our in vitro studies, we examined the relationship between in vivo insulin concentration and muscle INSR level in mice. As in our previous studies (12) , insulin gene dosage was manipulated (Ins1 +/+ ;Ins2 -/and Ins1 +/-;Ins2 -/-) to generate variance in circulating insulin. The mice were fed with high fat diet (HFD) known to induced pronounced hyperinsulinemia (12, 35) or low fat diet (LFD). These experiments showed that INSR protein abundance negatively correlated with both fasting insulin and fasting glucose in the HFD group ( Fig. 5A-B ). However, the LFD group only had a negative correlation between INSR level and insulin, with no correlation between INSR and glucose ( Fig. 5C-D) . These data support the concept that insulin, independent from glucose, can negatively regulate INSR levels in skeletal muscle, consistent with our in vitro hyperinsulinemia model and our previous in vivo data demonstrating improved insulin sensitivity over time in mice with genetically reduced insulin production (11) . These data also suggest an interaction between insulin, glucose and INSR that is dependent on the conditions of the HFD.
Discussion
The goal of this study was to explore the mechanisms of hyperinsulinemia-induced insulin resistance in skeletal muscle cells. We demonstrated that prolonged physiological and superphysiological hyperinsulinemia induced a reduction of AKT and ERK signaling. Remarkably, while serum starvation partially reversed the effects of overnight hyperinsulinemia, much of the impaired acute insulin signaling we observed after 16 hours of hyperinsulinemia was sustained after 6 hours of insulin withdrawal and serum starvation, suggesting that long-term molecular changes underlie these differences. The effects of prolonged hyperinsulinemia were dosedependent from the physiological to the superphysiological range. We demonstrated that the impaired insulin response in our system can be accounted for by INSR downregulation at the transcription level via FOXO1 phosphorylation. We validated our in vitro system in vivo in mice with varying degrees of diet-induced hyperinsulinemia.
Our in vitro cell culture model provided a robust and controlled system for examining the direct effects of excess insulin, and insulin withdrawal, on multiple components of insulin signaling.
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Our results are consistent with other in vitro cell culture systems designed to examine the effects of hyperinsulinemia. For example, reduced AKT and ERK signaling and INSR abundance were also reported in hyperinsulinemia-treated β-cells (INS1E cell line and rat islets) and enteroendocrine L cells (36, 37) . The molecular mechanisms mediating the down-regulation of signaling components are unclear, but we speculate that the proteosome may be involved because IGF1 treatment can cause proteasome-dependent downregulation of AKT protein (41) .
The mechanisms of sustained alterations in AKT and ERK phosphorylation are also not fully understood. In our experiments, there was suppressed AKT and ERK phosphorylation at all time points, suggesting that the insulin resistance we observed was impaired responsiveness consistent with signaling deficiencies at both the receptor level and in post-receptor components (40) . Our observations verified the distinct responses to hyperinsulinemia of the bifurcate insulin signaling pathways. Chronic 200 nM insulin treatment preferentially increased basal AKT phosphorylation, but did not increase the basal ERK phosphorylation, which is a result that has also been reported in neurons (38) . Diet and hyperinsulinemia-induced insulin resistance is generally considered to be related specifically to AKT phosphorylation. Interestingly, chemical inhibition of AKT pathway, but not ERK pathway, has been reported to protect insulin resistance both in vitro and in vivo (38, 39) . Further work is required to understand the interplay between INSR expression and downstream signaling.
The main finding of our study was that that hyperinsulinemia directly reduced Insr mRNA in cultured cells, consistent with reports from other cell culture systems (21, 42) . In a previous study, we observed a ~20% increase in Insr mRNA from skeletal muscle samples of Ins1 +/-;Ins2 -/mice compared to Ins1 +/+ ;Ins2 -/mice, as well as a trend of a ~50% increase in Foxo1 mRNA (12) . Our in vivo data in mice are also consistent with the limited data from human studies. For example, T2D patients with higher fasting insulin were found to have lower Insr mRNA expression in skeletal muscle biopsies (43) . While relative hyperglycemia can increase Insr expression in lymphocyte and cancer cell lines (44, 45) , high glucose inhibits β-cell Insr expression through autocrine insulin action and INSR-FOXO1 signaling (44, 45) . Interestingly, glucose can only induce insulin resistance in the presence of insulin in cultured hepatocytes, adipocytes and skeletal muscle (20, 46, 47) . Therefore, reduced Insr expression by hyperinsulinemia may be a key, independent factor of INSR downregulation and insulin resistance.
Intermittent fasting, time-restricted feeding, caloric restriction, and/or carbohydrate restriction have been shown to have health benefits in diabetes, including reducing hyperinsulinemia, increasing insulin sensitivity, improving -cell responsiveness, and lowering the levels of circulating glucose (48) (49) (50) . Several human trials suggest that fasting regimes can be more effective for reducing insulin and increasing insulin sensitivity than they are for reducing glucose 7 (51, 52) . By mimicking the low-insulin state, the serum starvation phase of our studies revealed some possible molecular mechanisms of the beneficial effects of fasting, which includes the restoration of protein phosphorylation in insulin signaling pathways and partial recovery of Insr transcription and INSR protein. These data hint that many deleterious effects of hyperinsulinemia are reversible but may require a long enough low-insulin period.
The present study has limitations and unanswered questions. We employed a 16-hour insulin incubation instead of more chronic hyperinsulin treatment. The main reason for this is that insulin promotes the further differentiation of C2C12 myotubes (53) , meaning that chronic treatment during differentiation would likely introduce unmanageble variance in the muscle cell model.
Another limitation to our study is that it was not comprehensive with regards to key insulin signaling nodes. Indeed, hyperinsulinemia has been shown to downregulate other insulin signaling proteins such as IRS1 and IRS2 (54, 55) . In future studies, it would be interesting to examine the effect of hyperinsulinemia and fasting on other signaling molecules in our model to further dissect the cause of insulin resistance. Besides FOXO1, other transcription factors such as SP1, HMGA1, C/EBPβ, and NUCKS have been shown to regulate Insr expression (56) (57) (58) .
For example, HMGA1 is downregulated in diabetes, which inhibits Insr as well as Foxo1 transcription (57) . The roles of these other transcriptional regulators in hyperinsulinemia could be investigated in future studies using our system. INSR degradation and proteolysis are also prior to reaching day 10 ( Fig.1A) . Insulin concentrations after the 16 h hyperinsulinemia treatment were measured using human insulin RIA kit (Millipore). For serum starvation, myotubes were maintained in serum-free medium (DMEM supplemented with 1% penicillin-streptomycin) for 6 hours. All experiments were repeated with biological replicates using cells in different passages.
Experimental Animals
Animal protocols were approved by the University of British Columbia Animal Care Committee. Ins1 +/+ ;Ins2 -/and Ins1 +/-;Ins2 -/mice were randomly assigned to be fed ad libitum either a high fat diet (Research Diets D12492, 20% protein, 60% fat, 20% carbohydrate content, energy density 5.21Kcal/g, Brunswick, NJ, US) or low fat diet (Research Diets D12450B, 20% protein 10% fat, 70% carbohydrate content, energy density 3.82Kcal/g, Brunswick, NJ, US) for 4 weeks starting from 8 weeks old. Blood fasting glucose was measured using OneTouch Ultra2 glucose meters (LifeScan Canada Ltd, BC, Canada), and serum fasting insulin were assessed using mouse insulin ELISA kit (Alpco Diagnostics, Salem, NH, USA), following 4-hour fasting.
RNA isolation and quantitative real-time PCR analysis
Before and after serum starvation, total RNA was isolated from both control and high insulintreated C2C12 myotubes using the RNEasy mini kit (Qiagen). cDNA was generated by reverse transcription using qScript cDNA synthesis kit (Quanta Biosciences, Gaithersburg, MD, USA). 
Western blot analyses
C2C12 myotubes or mice skeletal muscle (gastrocnemius) tissues were sonicated in RIPA buffer (50 mM β-glycerol phosphate, 10 mM HEPES, 1% Triton X-100, 70 mM NaCl, 2 mM EGTA, 1 mM Na3VO4, and 1 mM NaF) supplemented with complete mini protease inhibitor cocktail (Roche, Laval, QC), and lysates were resolved by SDS-PAGE. Proteins were then transferred to PVDF membranes (BioRad, CA) and probed with antibodies against p-ERK1/2 (Thr202/Tyr204) The signals were detected by secondary HRP-conjugated antibodies (Anti-mouse, Cat. #7076;
Anti-rabbit, Cat. #7074; CST) and Pierce ECL Western Blotting Substrate (Thermo Fisher Scientific). Protein band intensities were quantified with Image Studio Lite software (LI-COR).
Surface Protein Biotinylation Assay
Biotinylation of surface proteins was performed as previously described(62) with modifications ( Fig. 5A) . In brief, cells were incubated with cell-impermeable EZ-Link-NHS-SSbiotin (300 μg/ml in PBS; Pierce) at 37°C for 2 min. Cells were then immediately placed on ice and washed with ice-cold 50 mM Tris-buffered saline (TBS) to remove excess biotin. For isolating surface proteins, cells were washed using ice-cold PBS and lysed in complete RIPA buffer (supplemented with cOmplete mini protease inhibitor cocktail (Roche, Laval, QC) and Na3VO4). Acknowledgments: We acknowledge Dr. Brain Rodrigues for providing the C2C12 cells. We thank our colleagues Xiaoke Hu and Leanne Beet for performing the RIA insulin measurement.
Contributions: HC designed the study, performed all experiments except the high-fat feeding, analyzed data and wrote the manuscript. JDB performed in vivo high fat feeding and analyzed the related data. SW performed statistical analysis and edited the manuscript. JDJ designed the study, supervised the research and edited the manuscript. JDJ is the ultimate guarantor of this work.
Funding: This study was funded by a CIHR Operating Grant to JDJ.
Conflict of interest:
The authors declare that they have no conflicts of interest with the contents of this article. 
